Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: CareDx Inc., 3 years.
CareDx Inc.
Director
BridgeBio Pharma Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2024 | Pacific Biosciences of California Inc. | Grant or award | +22,821 | — | — |
| Jun 14, 2024 | CareDx Inc. | Grant or award | +10,570 | — | — |
| Feb 15, 2024 | BridgeBio Pharma Inc. | Option exercise | +2,915 | $8.45 | $24,632 |
| Feb 15, 2024 | BridgeBio Pharma Inc. | Open-market sale | −2,915 | $37.75 | $110,041 |
| Jan 16, 2024 | BridgeBio Pharma Inc. | Option exercise | +2,915 | $8.45 | $24,632 |
| Jan 16, 2024 | BridgeBio Pharma Inc. | Open-market sale | −2,915 | $37.97 | $110,683 |
| Dec 15, 2023 | BridgeBio Pharma Inc. | Option exercise | +2,915 | $8.45 | $24,632 |
| Dec 15, 2023 | BridgeBio Pharma Inc. | Open-market sale | −2,915 | $36.12 | $105,290 |
| Nov 15, 2023 | BridgeBio Pharma Inc. | Option exercise | +2,915 | $8.45 | $24,632 |
| Nov 15, 2023 | BridgeBio Pharma Inc. | Open-market sale | −2,915 | $30.00 | $87,450 |
| Jun 16, 2023 | CareDx Inc. | Grant or award | +18,844 | — | — |
| Jan 6, 2023 | CareDx Inc. | Grant or award | +676 | — | — |
| Dec 28, 2021 | BridgeBio Pharma Inc. | Open-market purchase | +1,891 | $13.18 | $24,923 |
| Dec 28, 2021 | BridgeBio Pharma Inc. | Open-market purchase | +1,891 | $13.18 | $24,923 |
| Dec 28, 2021 | BridgeBio Pharma Inc. | Open-market purchase | +1,542 | $12.68 | $19,553 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.